Financial implications of Bear buying Monsanto

The speakers discuss Bear's poor stock performance compared to the European market and the potential liabilities they face after buying Monsanto. They speculate about incriminating documents proving Bear knew their product was causing cancer. They also discuss the significance of a recent verdict related to Monsanto and its challenge to the idea of hiding behind the EPA.